Onderneming BioPlus Acquisition Corp. Nasdaq
Aandelen
BIOSU
KYG112171098
Holdingvennootschappen
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Corporate Officer/Principal | 53 | - | |
Steven Fletcher
PRN | Corporate Officer/Principal | 56 | - |
Alex Serge Vieux
PRN | Corporate Officer/Principal | 66 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01-12-21 |
Jonathan Rigby
CHM | Chairman | 56 | 01-07-21 |
Louis Lange
BRD | Director/Board Member | 72 | 01-12-21 |
Ronald Eastman
BRD | Director/Board Member | 71 | 01-12-21 |
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Shawn Cross
BRD | Director/Board Member | 56 | 01-12-21 |
Glen Giovannetti
BRD | Director/Board Member | 61 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 750 000 | 0 | 0 | 29,61 % |
Aandeel B | 1 | 19 367 477 | 7 437 478 ( 38,40 %) | 0 |
Bedrijfsgegevens
BioPlus Acquisition Corp.
260 Madison Avenue Suite 800
10016, New York
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+181,49% | 6,73 mld. | |
+18,11% | 1,17 mld. | |
+2,19% | 982 mln. | |
+41,91% | 872 mln. | |
+22,24% | 799 mln. | |
+11,31% | 675 mln. | |
+1,72% | 664 mln. | |
+43,66% | 654 mln. | |
-.--% | 600 mln. |